Kyphoplasty Market Size, Share & Trends Analysis Report By Product (Balloon Catheters, Bone Access Devices, Cement Application Products, Instruments), By Application, By Indication, By End Use, By Region, And Segment Forecasts, 2022 - 2030

Report Overview

The global kyphoplasty market size was valued at USD 606.01 million in 2021 and is expected to expand at a CAGR of 5.2% during the forecast period. The rising base of the geriatric population and the increasing prevalence of osteoporosis are high growth rendering drivers for the market growth. Consistent with the International Osteoporosis Foundation, it is assessed that 1 in 5 men and 1 in 3 women and, over age 50, will experience osteoporosis fractures in their remaining lifetimes globally. Vertebral compression fractures untreated can have serious clinical consequences and impose a significant impact on patients' quality of life and on caregivers. Since non-surgical management of these fractures has limited effectiveness, kyphoplasty procedures are gaining acceptance in medical practice for fracture stabilization and pain control. Furthermore, vertebral augmentation procedures for instance balloon kyphoplasty have been displayed to reduce mortality by up to 55% compared to non-surgical management.

COVID-19 has spread all over the globe and has touched the epidemiologic criteria to be defined as a pandemic. In this alarming situation, standard medical practice was markedly affected, giving importance to the treatment of Coronavirus patients. To reduce the rate of contamination of medical staff and patients during hospitalization, the spine department was totally reorganized. In April 2020, the North American Spine Society (NASS) released a guidance document comprehensive of clinical considerations and recommendations for surgeries and procedures within the following classes: emergent, urgent, and elective.

Non-urgent elective surgeries were annulled. For instance, as per a study published in Asian Spine Journal, surgical procedures decreased by approximately 50% in the first month of confinement in France as compared to the same period in 2019 (March 2020 to April 2020). The pandemic is estimated to have a modest impact on the market in the short term. Once the impact decreases, acceptance of innovative devices, as well as the ongoing expansion of dedicated infrastructure for spinal interventions, will drive strong growth throughout the forecast period.

Innovations and the development of new technologies, based on research activities undertaken by manufacturers, are driving the growth of the market. For instance, in October 2021, Stryker set up an R&D lab in Australia (Queensland), which builds on the existing partnerships with researchers, hospitals, universities, and local governments, to drive the transformation of research into practical, commercially accessible precision medical device technology. This innovative R&D Lab will also associate with the company’s CMF instruments and endoscopy, medical, joint replacement, spine, & trauma, and extremities divisions to focus on research that drives technology platforms that can be used across facility lines over the continuum of care

The kyphoplasty procedure can reduce pain while improving mobility and alignment. This, along with reduced dependence on opioid pain medication, can result in significantly enhanced overall quality of life. Kyphoplasty has the added advantage of improving or restoring vertebral body height and mechanical alignment at the fracture site. The kyphosis and height loss related to compression fractures can lead to reduced pulmonary capacity and poor quality of life. Kyphoplasty procedures are safe, proven, and minimally invasive techniques. They provide relief of pain and fracture stabilization in individuals who are treated using this procedure.

The balloon kyphoplasty procedure has been in usage for over 20 years in more than 1 million fractures. As compared to non-surgical procedures, balloon kyphoplasty has been displayed in clinical studies to attain restoration of vertebral body height and improvement of vertebral body deformity. Besides, improved quality of life, mobility, and ability to do daily activities reduced back pain further making this procedure more advantageous over others, which in turn, supports market growth.

So far, a comprehensive range of bone cement has been approved for clinical applications and many have been used for balloon kyphoplasty procedures. New technical improvements in the development of balloon kyphoplasty cement rely on innovative concepts and interdisciplinary knowledge. With the advent of novel biodegradable and mechanically matched bone cement, the balloon kyphoplasty indications will likely be broadened, thus supports in segment growth. The preference for less invasive procedures has been shown as a key trend in the global kyphoplasty market.

Moreover, increasing demand for minimally invasive surgical procedures in orthopedics, increasing health expenditure, and improving health reimbursements are likely to drive the market growth during the forecast timeline. For instance, in September 2020, Stryker’s SpineJack implantable fracture reduction system received the U.S. Centers for Medicare & Medicaid Services (CMS) new technology add-on payment as part of the 2021 inpatient prospective payment system.

An upsurge in the number of spine fractures is also anticipated to fuel the global kyphoplasty industry growth. CMS is focusing its efforts to enhance price transparency, holding hospitals accountable, and ensuring consumers have the information they require to make fully informed decisions regarding their health care. However, product recalls, such as Device Recall of KyphX HVR Bone Cement, may hamper the market growth.

Product Insights

Bone access device segment held the largest revenue share of 42.0% in 2021. Needles provide control & flexibility in accessing the vertebral body and delivering bone cement during vertebral compression fracture treatments. Globally, the prevalence of spine fractures and back pain is increasing at an exponential rate. Around 2% of American laborers suffer compensable back injuries annually—500,000 cases. Low back pain accounts for 19% of all labor compensation claims in the U.S. Thus, growth in the prevalence of such disease conditions is expected to impel market growth.

On the other hand, the balloon catheters segment is expected to witness lucrative growth over the forecast period owing to the growing number of technological advancements with the advent of next-generation kyphoplasty balloons, enabling efficient procedures in the market. Besides, new product launch further contributes to market growth. For instance, in January 2020, Merit Medical Systems, Inc. proclaimed the introduction of Arcadia Steerable and Straight Balloons for vertebral augmentation.

Application Insights

The spinal fractures segment is estimated to account for the largest market share and witnessed lucrative growth due to the high adoption of kyphoplasty procedures for this application. Rising incidences of compressed bones of the spine due to cancer, and trauma have led to the growth of the market. The bones of people with cancer and elderly people can break easily with no or little force, therefore, increasing the incidences of cases leading to an increase in demand for kyphoplasty procedures.

Compression fractures affect many individuals worldwide. Vertebral compression fractures (VCFs) are the most common fracture in osteoporosis patients, affecting approximately 750,000 people every year. The occurrence of this condition gradually rises as people age, with an estimated 40% of women aged 80 and older affected. Therefore, supports overall market growth.

Indications Insights

Osteoporosis segment held the largest revenue share of over 57.0% in 2021. The increasing prevalence of osteoporosis can be attributed to the large market share of the segment over other segments. Osteoporosis is a chronic bone illness that is characterized by low bone mineral density, leading to reduced bone quality and an augmented susceptibility to fracture. According to the studies conducted among women in India, it is projected that among the 230 million Indians anticipated to be over the age of 50 years, 46 million are women with osteoporosis.

Alternatively, others segment is expected to witness lucrative growth over the forecast period. Kyphoplasty is commonly used in the palliative treatment of metastatic vertebral tumors. From the viewpoint of aging patients in the U.S., kyphoplasty is cost-effective compared to nonsurgical treatment. As per a study published in the National Library of Medicine, the kyphoplasty procedure significantly and rapidly reduced pain intensity in cancer patients with VCFs.

End-use Insights

The hospitals segment held the largest share of the market in 2021 and is anticipated to continue leading the market over the forecast period. Hospitals are the primary point of care for all kinds of health problems, due to which the segment is anticipated to hold the largest market size in the global market. Hospitals are an integral part of the healthcare industry and are the main revenue source for the entire sector, which drives research and innovation. Consequently, numerous corporations are making significant efforts, both in terms of revenue & marketing strategies, to endorse their product/services in hospitals.

The Ambulatory Surgical Centers (ASC) segment is expected to witness the fastest growth over the forecast period. An ambulatory surgery center offers a convenient substitute to hospitals with the same quality of care at a lower cost to individuals. The increase in outpatient admissions can also be attributed to the growing acceptance of technologically advanced techniques in centers, rendering treatment cost-effective and speedier. Innovative surgical methods in such settings allow tests and procedures to be performed without hospital admission. This is expected to support segment growth.

Regional Insights

North America accounted for the largest revenue share in 2021 owing to high awareness levels and improved healthcare infrastructure. The dominance can be attributed to the rising prevalence of osteoporosis, back pain, and spine fractures. This disease has been mostly seen in females compared to men in the region. The surge in the adoption of kyphoplasty and the growing burden of vertebral compression fractures are fueling the market growth. Currently, key companies such as Medtronic and Stryker and major revenue contributors undertake acquisitions and partnerships to propel market growth.

The Asia Pacific market is presumed to witness the fastest growth due to the growing patient pool and rising healthcare infrastructure. The increasing older population and growing acceptance of the procedure are aiding the market growth. Similarly, factors such as availability of advanced methods in fracture stabilization, limitations of the conventional approach, increasing incidence of vertebral compression fracture, rising cases of osteoporosis, improvement in health care infrastructure, and growth in patient compliance because of technological advancements are some of the others key aspects driving Asia Pacific market.

Key Companies & Market Share Insights

The key players are involved in various strategies such as new product developments, distribution agreements, and expansion strategies to improve their market penetration. For instance, in August 2020, IZI Medical announced the introduction of an Osteo-site Vertebral Balloon for vertebral augmentation. The novel Osteo-site Vertebral Balloon is intended to form a cavity within the vertebral body. This launch helped the company expand its product portfolio. Likewise, in June 2020, Joline GmbH & Co. KG received U.S. FDA approval for Joline Kyphoplasty products to treat vertebral compression fractures. Some of the prominent players in the global kyphoplasty market include:

• Stryker

• Medtronic Inc.

• Smith & Nephew

• MicroPort Scientific Corporation

• DePuy Synthes (Johnson & Johnson Services Inc.)

• IZI Medical Products

• CareFusion

• Merit Medical Systems

• joimax GmbH

• G21 S.r.l.

• Joline GmbH & Co. KG

• Seawon MediTech

• Hensler Surgical Products

• Taeyeon Medical Co., Ltd.

• iMEDICOM

• Jiangsu ChangMei Medtech Co., Ltd.

Kyphoplasty Market Report Scope

Segments Covered in the Report 

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For the purpose of this study, Grand View Research has segmented the global kyphoplasty market report on the basis of product, application, indication, end-use, and region:

• Product Outlook (Revenue, USD Million, 2017 - 2030)

  • Balloon Catheters

  • Bone Access Devices

  • Cement Application Products

  • Bone Cement

  • Cement Mixing Systems

  • Instruments

• Application Outlook (Revenue, USD Million, 2017 - 2030)

  • Vertebral Alignment Restoration

  • Spinal Fractures

  • Kyphosis

• Indication Outlook (Revenue, USD Million, 2017 - 2030)

  • Osteoporosis

  • Others

• End-Use Outlook (Revenue, USD Million, 2017 - 2030)

  • Hospitals & Clinics

  • Ambulatory Surgical Centers

• Regional Outlook (Revenue, USD Million, 2017 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East and Africa

    • South Africa

    • Saudi Arabia